Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse  by Williams, Helen et al.
E
s
H
R
a
b
c
a
A
R
R
A
A
K
T
A
P
C
M
1
a
a
a
a
r
a
p
c
c
s
s
0
dAtherosclerosis 210 (2010) 94–99
Contents lists available at ScienceDirect
Atherosclerosis
journa l homepage: www.e lsev ier .com/ locate /a therosc leros is
ffect of transglutaminase 2 (TG2) deﬁciency on atherosclerotic plaque
tability in the apolipoprotein E deﬁcient mouse
elen Williamsa,1, Richard J. Peaseb,1, Laura M. Newell a, Paul A. Cordellb,
obert M. Grahamc, Mark T. Kearneyb, Christopher L. Jacksona,∗, Peter J. Grantb
Bristol Heart Institute, University of Bristol, Level 7, Bristol Royal Inﬁrmary, Bristol BS2 8HW, UK
Division of Cardiovascular and Diabetes Research, Leeds Institute of Genetics Health and Therapeutics, University of Leeds, Leeds LS2 9JT, UK
Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia
r t i c l e i n f o
rticle history:
eceived 13 February 2009
eceived in revised form 14 October 2009
ccepted 15 November 2009
vailable online 20 November 2009
eywords:
ransglutaminase 2
polipoprotein E
laque stability
alciﬁcation
a b s t r a c t
Background: Transglutaminase 2 (TG2), a cross-linking enzyme that confers supra-molecular structures
with extra rigidity and resistance against proteolytic degradation, is expressed in the shoulder regions
of human atherosclerotic plaques. It has been proposed that TG2 prevents tearing and promotes plaque
repair at these potential weak points, and also promotes ectopic calciﬁcation of arteries. TG2 is also
expressed within plaques that develop within the brachiocephalic arteries of apolipoprotein E (apoE)
deﬁcient mice.
Objectives: To determine the role that TG2 plays in plaque development and calciﬁcation, mice were bred
that were doubly deﬁcient in apoE and TG2, and were maintained on a high-fat diet for 6 months.
Results: Lesion size and composition were not signiﬁcantly altered in the apoE/TG2 double-knockout
mice, with the exception of a 9.7% decrease in the proportion of the plaque occupied by lipid (p=0.032).ouse The frequency of buried ﬁbrous caps within brachiocephalic plaques was signiﬁcantly higher in male
than in female mice, but TG2 deﬁciency had no effect on either gender. The extent of lesion calciﬁcation
varied markedly between individual mice, but it was not decreased in the apoE/TG2 double-knockout
mice.
Conclusion: These data indicate that, in the apoE knockout mouse model of atherosclerosis, TG2 does
not inﬂuence plaque composition or calciﬁcation. The data further suggest that TG2 does not inﬂuence
in theplaque stability or repair
. Introduction
Plaque rupture exposes the internal constituents of the
therosclerotic plaque to the blood-stream. This promotes platelet
dhesion and blood coagulation, leading to thrombosis within the
ffected artery. In humans, approximately 90% of these events
re repaired asymptomatically [1]. Repeated cycles of rupture and
epair can occur, but a strong ﬁbrous cap covering the lesion
nd decreased plaque lipid content are associated with increased
laque stability. Atherosclerosis is also associatedwith arterial cal-
iﬁcation, the extent of which strongly predicts the incidence of
ardiovascular events [2].
Tissue repair and stabilization involve the incorporation of
tructural proteins into the extracellular matrix and their sub-
equent remodelling by proteinases and cross-linking enzymes.
∗ Corresponding author. Tel.: +44 117 928 2534; fax: +44 117 928 2534.
E-mail address: chris.jackson@bristol.ac.uk (C.L. Jackson).
1 These authors made equal contributions to this study.
021-9150 © 2009 Elsevier Ireland Ltd. 
oi:10.1016/j.atherosclerosis.2009.11.014
Open access under CC BY-NC-ND license.se mice.
© 2009 Elsevier Ireland Ltd. 
Amongst the various cross-linking enzymeswhich protect proteins
from proteolysis and mechanical disruption is transglutaminase
2 (TG2) (reviewed in [3,4]). Despite lacking a conventional signal
sequence, TG2 is exported from cells in response to stress, enabling
it to associate with and to cross-link extracellular matrix proteins
[3,4]. TG2 on the surface of macrophages also facilitates apoptotic
cell engulfment [5,6]. IntracellularTG2activity is suppressedwithin
healthy cells, but becomes activated following injury and cross-
links cellular components to minimize pro-inﬂammatory leakage
[4]. TG2may therefore playmultiple roles in the body’s response to
tissue damage, and it is induced in human atherosclerotic plaques
where it may stabilize against rupture [7,8]. Recently it has been
suggested that TG2 enables smooth muscle cells to transform into
chondrocyte-like cells [9], thus promoting ectopic calciﬁcation of
atherosclerotic arteries and exerting deleterious as well as beneﬁ-
Open access under CC BY-NC-ND license.cial effects on lesion development [10].
Apolipoprotein E (apoE) deﬁcient mice, maintained on a high-
fat diet, develop advanced and complex plaques in the proximal
brachiocephalic artery [11–13], although such plaques are rare at
other anatomical sites [14]. It has been proposed that these plaques
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ndergo cycles of rupture and repair [14]. The use of mice dou-
ly deﬁcient for apoE and for individual proteinases has identiﬁed
ome that promote lesion development, while indicating others
hatmaybeprotective [15,16].Weareusing ananalogous approach
o deﬁne the roles of the transglutaminases, examining, in the ﬁrst
nstance, TG2. TG2 is awidely expressed and abundant protein, and
nlike most other abundant transglutaminases, which have very
estricted tissue distributions and functions, TG2 has been impli-
ated in arterial repair. Mice with a targeted disruption of the TG2
ene develop normally for the ﬁrst year of life [17,18] but subse-
uently develop mild abnormalities including glucose intolerance
19]. In the present study, apoE/TG2 double-knockout mice were
red and were compared (at less than 12 months of age), with
atched apoE single knockout controls to determine the role of
G2 in plaque rupture and repair and in arterial calciﬁcation.
. Materials and methods
.1. Animals
The maintenance of the animals, and the procedures used in
hese studies, were performed in accordance with the guidelines
nd regulations of the University of Bristol and the United King-
om Home Ofﬁce. ApoE [20] and TG2 [17] single knockout mice,
oth on amixed C57BL/6, 129 strain background, were crossed and
hedoubly heterozygous F1micewere interbred. Tail-tipDNA from
he F2 mice and subsequent litters was genotyped by PCR. In the
2 generation, only 1 double homozygote was obtained among 98
ice (p<0.02 for 1 or 0). Relative frequencies of the other geno-
ypes were as expected. Intercrossing of apoE−/−TG2+/− F2 mice
ielded only 10 double homozygotes among 98 mice (p<0.01 for
0 or fewer). However, the resulting double homozygotes bred suc-
essfully, generating sufﬁcient apoE−/−TG2−/− mice for study. ApoE
ingle knockout littermatesof thedouble-knockoutmicewereused
o generate apoE−/−TG2+/+ controls.
.2. Experimental design
Fuller experimental details are included in the online supple-
ent. Brieﬂy, starting at 6–8weeks of age, 51 apoE single knockout
nd 66 apoE/TG2 double-knockout mice were maintained for 6
onths on a high-fat rodent diet. Parafﬁn sections of mouse bra-
hiocephalic arterieswereused tomeasure theparameters listed in
able 1 [13], for immunohistochemistry and to detect the presence
f Ca3(PO4)2 deposits. Aortic sinuses from 24 randomly selected
ice (six males and six females per genotype) were also processed
o assess atherosclerosis. In all cases, plaque morphometry was
nalysed in a blinded fashion.
.3. Immunohistochemical analysis
Sections (3m) of human carotid artery atheroma or mouse
rtery were incubated with rabbit anti-guinea pig TG2 anti-serum,
r with a mouse monoclonal antibody to -smooth muscle actin.
ound antibodies were complexed with peroxidase-linked sec-
ndary antibodies and detected with diaminobenzidine. Sections
ere counterstained with haematoxylin..4. Determination of calcium deposits
De-waxed sectionswere stainedwith 2% Alizarin Red S inwater
H 6.8, washed extensively and then counterstained with 0.005%
ast Green. Ta
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Fig. 1. Mouse proximal brachiocephalic artery plaques. Scale bar represents 25m in Panels B, D, F and H. Panel (A): TG2 wild-type mouse stained for TG2. TG2 antigen
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.5. Statistical analysis
Double-knockout group values were compared with apoE sin-
le knockout controls using the computer programs InStat and
rism (both GraphPad Software, San Diego, CA, USA). Means were
ompared using an unpaired two-tailed Student’s t-test, applying
elch’s correction in instances where variances were signiﬁ-
antly different. Data that were discontinuous (incidence of buried
brous layers) or not normally distributed (lesion calciﬁcation)
ere analysed using the Mann–Whitney test. The correlation
etween plaque rupture and calciﬁcation was assessed by Spear-
an’s test. Results are shown as the mean± SEM. Statistical
igniﬁcance was concluded where the probability was less than
.05.
. Results
.1. Plasma analysis
Blood samples obtained at termination from the fat-fed mice
ere used either for lipid measurements or for determining
nsulin and glucose concentrations. There were no signiﬁcant
ifferences in ﬁnal mean lipid values between 26 apoE single
nockout and 20 TG2 apoE double-knockout mice: total choles-
erol, 19.7±1.6mmol/L and 18.8±1.4mmol/L respectively; HDL
holesterol, 1.1±0.1mmol/L and 1.1±0.1mmol/L; LDL choles-
erol, 18.3±1.6mmol/L and 17.4±1.5mmol/L; triacyglycerols,
.11±0.1mmol/L and 1.1±0.2mmol/L. Blood obtained from 18
poE single knockout and 12 TG2 apoE double-knockout mice
howed no signiﬁcant differences in mean plasma insulin levels
0.70±0.18ng/mL and 0.48±0.13ng/mL respectively, p=0.37), or
lasma glucose levels (8.20±0.87mmol/L and 7.56±0.77mmol/L
espectively, p=0.616).
.2. Immunohistochemistry
The commercial TG2 anti-serum detected a single band in
otal mouse liver proteins that co-migrated with guinea pig liver
G2 (not shown). The speciﬁcity of immunohistochemical stain-
ng of the TG2 anti-serum was conﬁrmed by showing that staining
as minimal in spleen from TG2 knockout mice but abundant in
pleen fromwild-typemice, and that the antibody strongly staineder region and in the necrotic core, but is not present on the cap surface. Panel (B):
mouse processed without the primary antibody. Panel (D): Higher power detail of
): Higher power detail of view of part of Panel E. Panel (G): TG2 wild-type mouse
l G.
capillary endothelial cells in intestinal villi (Supplementary Fig.
1). In agreement with previous reports, the antibody intensely
stained formations of cells in the shoulder regions of human carotid
atherosclerotic plaques including the intima of capillaries within
the arterial wall (Supplementary Fig. 2). The TG2 antibody strongly
stained intact endothelium in brachiocephalic arteries from apoE
deﬁcient mice TG2 but also detected small clusters of cells within
the shoulder regions of mouse plaques and within the core of the
plaque (Fig. 1).
3.3. Vessel morphometry
The overall extent of atherosclerosis and other morphometric
characteristics examined in fat-fed apoE knockout mice was gen-
erally unaffected by the presence or absence of TG2 (Table 1).
However, the plaque lipid content was slightly decreased from
38.1±1.3% to 34.4±1.1% in apoE/TG2 double-knockout animals
(p=0.032). Also, ﬁbrous cap thickness was increased signiﬁcantly
from 2.8±0.3m to 4.1±0.5m in male double-knockout mice
(p=0.028). This effect lost statistical signiﬁcance when the gen-
ders were combined (p=0.135). Additionally, aortic sinus plaques
were measured in a sample of 12 single and 12 double-knockout
mice. Vessel cross-sectional area was essentially identical between
the two groups, and there were no signiﬁcant differences in aortic
sinus morphological characteristics (Supplementary Table 1 and
Supplementary Fig. 3).
3.4. Buried and ruptured ﬁbrous caps
The frequency of buried caps per mouse was signiﬁcantly
greater in males than females (2.21±0.18 vs. 1.66±0.17 respec-
tively, p=0.021), but there was no effect of TG2 deﬁciency in
either sex. Up to six buried caps were detected in individual
double-knockoutmice (Fig. 2A). Rare instances of current unhealed
ruptures were also observed (Fig. 2B) and occurred at similar fre-
quencies in both groups (apoE/TG2 double-knockouts: 1 observed
in 66 mice; apoE single knockouts: 2 observed in 51 mice).3.5. Calciﬁcation
Complexing Ca3(PO4)2 deposits with Alizarin Red S [21] in sec-
tions from 28 randomly selected mice showed that the extent
H. Williams et al. / Atheroscle
Fig. 2. Sections of mouse brachiocephalic plaques stained for elastin. Scale bars
represent 200m in Panel A and 100m in Panel B. Panel (A): Multiple buried
caps (arrowheads) present in a plaque from an apoE/TG2 double-knockout mouse.
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arrowhead). Red blood cells have permeated the plaque at the point of rupture.
f calciﬁcation varied widely within both the single and double-
nockout groups.Humancarotidplaqueswereprocessed alongside
s a positive control (Fig. 3). When expressed either as whole
issue section calciﬁcation (calciﬁed area/total tissue area) or as
nterlamellar calciﬁcation (calciﬁed media area/total media area),
here were no signiﬁcant differences between groups (apoE/TG2
ouble-knockouts: tissue section 0.60±0.22%,media 1.41±0.49%;
poE single knockouts: tissue section 0.25±0.08% (p=0.181),
edia 0.61±0.20% (p=0.165). It thus appears that TG2 is not
equired for arterial calciﬁcation. In human subjects, calciﬁca-
ig. 3. Sections of human carotid andmouse brachiocephalic arteries stained for calcium.
nd E. Panel (A): Crystalline calcium deposits in a longitudinal section of a human carotid
alciﬁcation of both the plaque and arterial wall in a lesion from the brachiocephalic arter
f the lesion shown in Panel C. Panel (E): Low to moderate calciﬁcation in the brachioceprosis 210 (2010) 94–99 97
tion is associated with advanced atherosclerosis [2]. However,
no correlation was apparent between the incidence of buried
plaques and plaque calciﬁcation amongst the mice sampled
(p=0.974).
4. Discussion
Transglutaminase 2 (TG2) is induced at sites of tissue injury
including atherosclerotic plaques [7,8] and is strongly expressed in
endothelial cells where it establishes a protective barrier against
permeation and invasion of foreign cells into the vessel wall
[4].
We could readily detect TG2 within human arterial plaques
(Supplementary Fig. 1), and observed staining of small islands of
TG2-positive cells in the shoulder regions ofmousebrachiocephalic
plaques. As expected, TG2 was detected on mouse endothelial
cells. Despite this, we did not observe any increase in plaque vol-
ume or gross changes in plaque composition in brachiocephalic
arteries or aortic sinuses in apoE/TG2 double-knockout mice.
While we observed a slight and unexpected reduction in bra-
chiocephalic plaque lipid accumulation in the double-knockout
animals (Table 1), it is unclear whether this is biologically signiﬁ-
cant. Similarly, a statistically signiﬁcant increase in cap thickness
was observed in male mice, but this was due to large changes
in a few animals rather than a consistent increase across the
group. Of greater importance, we did not see the major changes
that would be anticipated if TG2 limited lipoprotein permeation
into the arterial wall or if TG2 promoted macrophage-mediated
clearance of plaque material. Some caution must be exercised
in extrapolating to the human situation, since the accelerated
atherosclerosis induced in fat-fed apoE knockout mice could have
overwhelmed the protection that TG2 affords in slowly devel-[22] observed increases in total, and necrotic core size of aor-
tic sinus lesions size using LDL-receptor knockout mice that had
been transplanted with TG2 knockout as opposed to TG2-wild-
type bone marrow. They also reported qualitative differences in
Scale bars represent 500m in Panel A, 100m in Panels B and C, 50m in Panels D
arterial plaque. Panel (B): Higher power view of part of Panel A. Panel (C): Extensive
y of an apoE/TG2 double-knockout mouse. Panel (D): Higher power view of a region
halic artery of an apoE single knockout mouse.
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laque appearance, althoughweobserved very similar plaquemor-
hology irrespective of the presence of TG2 (Supplementary Fig.
). Boisvert et al. also reported differences in macrophage distri-
ution within the plaques which might account for differences in
laque composition, but assuming that TG2 is necessary for opti-
almacrophage function [5,6], this requirement can onlymanifest
n vivo under particular sets of conditions otherwise TG2 knockout
ice would exhibit severe developmental abnormalities. Since we
bserved very similar plasma lipid proﬁles in TG2+/+ and TG2−/−
ice, it is unlikely that a compensatory change in lipid levels was
nducedby the breeding strategywhich offset the deleterious effect
f TG2 deﬁciency. Although there was some variability in random
lucose and insulin levels at termination, the differences between
enotypes were not statistically signiﬁcant difference and could
ot have masked a protective effect of TG2. Older TG2−/− mice
ecome insulin resistant [19], but if this occurred in the current
tudy, TG2 deﬁciency would be expected to promote atherosclero-
is and hence bias towards a protective effect for TG2, rather than
o effect.
Lesionswithin the brachiocephalic artery display a layeredmor-
hology, interpreted as arising from the burying of ﬁbrous caps
ollowing successive rounds of plaque rupture [14]. Our data there-
ore suggest that TG2 is essential neither for the repair of previous
uptures in mice (since up to six buried caps were detected in
ndividual TG2 deﬁcient mice), nor for stabilizing plaques (since
requencies of buried caps were similar in both groups). We have
lso assessed current acute ruptures in TG2-deﬁcient mice, where
rythrocyte intrusion into the plaque is apparent. These events,
lthough rare, occur with similar frequency in both groups, rein-
orcing the suggestion that lesions in TG2-deﬁcient mice are not
endered unstable.
Johnson et al. suggested that TG2 is essential for the ectopic cal-
iﬁcation of arteries, since cultured TG2-deﬁcient arterial smooth
uscle cells were unable to differentiate to chondrocytes and
alcify [9]. This failure was partially reversed with exogenous
XIIIA [9], a situation which resembles the model proposed
or bone calciﬁcation where TG2 and FXIIIA have overlapping
unctions [23]. Here, we observed that calciﬁcation was unim-
aired in apoE/TG2 double-knockout lesions, even within the
ntact arterial wall where permeation by blood-borne soluble FXI-
IA would be prevented. Matlung et al. recently reported that
XIIIA-positive macrophages co-localise with areas of calciﬁca-
ion within human lesions [24], and similarly macrophages could
elease FXIIIA into the mouse arterial wall. However, our recent
npublished observations indicate that TG2−/−FXIIIA−/− double-
nockout mice are viable and apparently normal and healthy at
months of age. This precludes the possibility that either one
f FXIIIA and TG2 is essential for bone calciﬁcation and possibly
herefore for arterial calciﬁcation. It also questions the proposed
verlap in roles of these enzymes in other processes relevant
o atherosclerosis, including physiological arterial remodelling
25].
In summary, we were unable to detect any protective role for
G2 against lesion development at either of two anatomical sites
n a large cohort of mice. We were unable to show any require-
ent for TG2 in arterial calciﬁcation. Further studies are planned
o examine these events in FXIIIA knockout and FXIIIA/TG2 double-
nockoutmice. These studieswill help to establishwhether plaque
ompositionandstabilityareprimarilymaintainedbyFXIIIA,which
tself has tissue repair activities [26,27], and whether one or the
ther enzyme must be present to enable arterial calciﬁcation or
hether there are unexpected roles for other members of the
ransglutaminase family. Deﬁning the role of these transglutam-
nases in arterial calciﬁcation versus tissue repair is important for
valuating their potential as therapeutic targets in atherosclero-
is.
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